The largest database of trusted experimental protocols

17 protocols using colchicine

1

Synthetic Hexaploid Wheat Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
In total, 26 Ae. umbellulata accessions from seeds supplied by the National BioResource Project-Wheat, Japan (https://shigen.nig.ac.jp/wheat/komugi/) were propagated from a single plant by self-pollination (Table 1). A tetraploid wheat accession T. turgidum ssp. durum cv. Langdon (Ldn) was used as the female parent and crossed with each of the 26 accessions of Ae. umbellulata (Fig 1). All 26 synthetic hexaploid wheat lines with the AABBUU genome (ABU hexaploids, F2 generation) were generated by 0.1% colchicine (Wako Pure Chemical Industries, Osaka, Japan) treatment for 5 h at the seedling stage in each F1 triploid hybrid (F1 generation). Thus, the synthetics share the A and B genomes from Ldn and contain the U genome derived from diverse Ae. umbellulata accessions. All synthetics grew normally in a greenhouse at Kobe University (34°43’N, 135°13’E), and none showed hybrid growth abnormalities such as SGA and GCD [29 (link)]. Four lines of synthetic hexaploid wheat with the AABBDD genome (ABD hexaploids), Ldn/KU-2097 (Syn6214), Ldn/IG126387 (Syn6240), Ldn/PI476874 (Syn6256), and Ldn/KU-2069 (Syn6262), were also used in this study. These four ABD hexaploids showed various heading/flowering time, and did not exhibit any growth abnormalities [37 ,39 ]. The ABD hexaploids were grown under the same conditions as the ABU hexaploids.
+ Open protocol
+ Expand
2

Culturing and Transfecting Drosophila S2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drosophila S2 cells were cultured in Schneider's Insect Medium (Gibco) supplemented with 10% FCS and antibiotics at 25°C (Schneider, 1972 (link)). pUAST vectors with actin5Ce-Gal4 drivers were cotransfected using Effectene (Qiagen) according to the manufacturer's instructions, and harvested 36-48 h after transfection. For immunofluorescence or time-lapse imaging, cells were replated on coverslips or glass-bottom dishes coated with Concanavalin A (Wako) and were allowed to spread for 1-2 h (Rogers et al., 2002 (link)). For drug treatments, cells were treated with 1 µM Latrunculin A (Wako) or 10 µM Colchicine (Wako) for 1 h before imaging. For immunofluorescence, cells were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 20 min at room temperature, permeabilized with 0.1% Triton X-100 in PBS (PBS-T) for 15 min, and blocked with 5% skimmed milk in Tris-buffered saline (TBS). Primary and secondary antibodies were diluted in the blocking solution. After each antibody incubation, the coverslips were washed three times with PBS-T. The cells were mounted in Vectashield mounting medium (Vector Labs).
+ Open protocol
+ Expand
3

Plaque Assay for Oncolytic Virus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated at 2 × 105/well in 6-well plates. After 36 h, cells were infected with OVV-LG at an MOI of 0.001. After a 1-h incubation, E-MEM containing 0.8% methyl cellulose supplemented with 5% FBS and reagents was added to each well, and plaque sizes were calculated with a BZ-X700 microscope. Reagents used for plaque assays were as follows: nocodazole (Wako, Osaka, Japan), colchicine (Wako), cytochalasin D (Wako), Rhosin (Merck, Boston, MA, USA), ML-141 (Sigma, St. Louis, MO, USA), and NSC23766 (Abcam, Cambridge, UK).
+ Open protocol
+ Expand
4

Cytotoxicity Assessment of Anticancer Drugs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Initially, 5×103 of PC9-KI, A375, and MDAMB231 cells were seeded on 96 well plates. After 24 h, 0.1 % DMSO or 10−5 μM, 10−4 μM, 10−3μM, 10−2μM, 10−1μM, 1 μM, or 10 μM of colchicine (WAKO), vincristine (Cayman), thapsigargin (WAKO), and ML-240 (Sigma Aldrich) were added. After 48h, 25 μL of Cell Titer Glo 2.0 (Promega) was added and incubated at 37°C for 30 min. Absorbance at 490 nm was measured using ARVO X3.
+ Open protocol
+ Expand
5

Colon Epithelial Cell Culture and Lentiviral Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
FHC, a human colon epithelial normal cells, were purchased from the American Type Culture Collection (ATCC, Manassas, VA) and cultured according to the recommended procedure by the supplier. HEK293T and CRC cells (Caco-2, COLO205, SW480, CW-2, LoVo, SW48 and HCT116) were obtained as reported previously (Inaguma et al., 2017 (link); Inoue et al., 2020 (link)). CRC cells were maintained in Dulbecco's Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS).
The lentivirus vectors for PBK and the control LacZ were constructed using the CSII-EF-MCS plasmid, which was kindly provided by Dr. H. Miyoshi (RIKEN BioResource Center, Tsukuba, Japan). The pcDNA3.1 vector (Invitrogen) was used to express PBK, CDH1cyt (CDH1 cytoplasmic domain, R733 to D882) or firefly luciferase (Luc2CP). The CDH1cyt mutants (CDH1cyt/S840,846,847A and CDH1cyt/S840,846,847D) were generated by PCR-based mutagenesis. The pGEX-5X-1 vector was used for the synthesis and purification of glutathione S-transferase (GST)-tagged proteins.
OTS514, a selective PBK inhibitor, was purchased from Selleck Biotech (Tokyo, Japan) and used to treat cells for 24–72 h. Colchicine was obtained from FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan) and added at a concentration of 1 × 10–7 M for 8 h. MG132, a proteasome inhibitor, was from Selleck Biotech (Tokyo, Japan) and applied at 1 µM for 8 h.
+ Open protocol
+ Expand
6

Endocytosis Inhibition Assay for Talaporfin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were suspended in DMEM or IMDM at 1.0 × 106 cells/mL in 1.5 mL microtubes. After the uptake of talaporfin, the following endocytosis inhibitors were added: 2‐deoxyglucose (2‐DG; Sigma‐Aldrich, St Louis, MO) at a concentration of 50 mmol/L), sodium azide (0.1% w/v; Kanto Chemical, Tokyo, Japan), methyl‐β‐cyclodextrin (5 mmol/L; Wako, Osaka, Japan), genistein (0.1 mmol/L; Wako), sucrose (0.45 M; Wako), chlorpromazine hydrochloride (20 mmol/L; Tokyo Chemical, Tokyo, Japan), cytochalasin β (1 mmol/L; Wako) and colchicine (1 mmol/L; Wako). After culture at 37°C for 30 minutes, the cells were chilled on ice for 30 minutes, washed three times with PBS, fixed with 0.5% formalin and analyzed by flow cytometry. For the inhibition of clathrin‐dependent endocytosis, Pitstop 2 (ab120687; Abcam, Cambridge, UK) was added to the serum‐free DMEM or IMDM to a final concentration of 25 μmol/L, and the cells were cultured at 37°C for 1 hour. Talaporfin was subsequently added to the cells to a final concentration of 30 μg/mL and the cells were washed three times with PBS, fixed with 0.5% formalin, and analyzed by flow cytometry.
+ Open protocol
+ Expand
7

Detailed Reagent Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eagle's minimal essential medium (E-MEM), MEM non-essential amino acids (MEM-NEAA) solution, penicillin–streptomycin solution (PS), Hank's balanced salt solution (HBSS), 0.25% w/v trypsin-1 mmol/L ethylenediamine tetraacetic acid·4 Na solution, ethanol, dimethyl sulfoxide (DMSO), sodium chloride, potassium chloride, disodium hydrogen phosphate, potassium dihydrogen phosphate, chloroform, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), sodium azide, colchicine, cytochalasin B, heparin sodium, and Lucifer yellow CH dilithium salt fluorescent stain (LY) were purchased from FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan). Fetal bovine serum (FBS) was purchased from Merck (Darmstadt, Germany). Acetonitrile was purchased from Nacalai Tesque Inc. (Tokyo, Japan).
+ Open protocol
+ Expand
8

Cell Cycle Analysis of ESCs and TESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ESCs and TESCs were incubated with 0.05 μg/mL colchicine (Wako) for 5 h. After trypsinization with PET solution, 1 × 106 cells were washed in 600 μL of ice-cold PBS, fixed in 1.4 mL of ice-cold 100% ethanol, and incubated for 1 h at 4°C. After removing the ethanol by centrifugation, the cells were resuspended in 1 mL PBS with 100 μg/mL RNase A and incubated for 1 h at RT. Next, 40 μL propidium iodide solution (40 μg/mL) was added to the cells, and the mixture was incubated for 5 min at RT and filtered through 40-μm mesh filters (Kyoshin Rikoh Inc., Tokyo, Japan) prior to analysis. Analysis was performed on a BD Accuri C6 Flow Cytometer (BD Becton, Dickinson and Company, NJ, USA).
+ Open protocol
+ Expand
9

Preparation of Pharmacological Compound Stock Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
BZ was purchased from Selleck Chemicals (Houston, TX, USA). Azithromycin dihydrate (AZM) was purchased from Tokyo Chemical Industry (Tokyo, Japan). PTX, VNR, and colchicine were obtained from Wako Pure Chemical Industries (Osaka, Japan). BZ was dissolved in dimethyl sulfoxide (DMSO) to make stock solution at a concentration of 1 mM. AZM and PTX were dissolved in 95% ethanol at a concentration of 5 mM as stock solutions. VNR was dissolved in distilled water to prepare a stock solution of 1 mM. colchicine was dissolved in 95% ethanol at a concentration of 10 mM as stock solution.
+ Open protocol
+ Expand
10

Cytotoxicity Screening of Drug Candidates

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, 4×104 of PC9-KI cells were seeded on 96 well plates. After 24 h, 0.1 % of DMSO or 10−5μM, 10−4μM, 10−3μM, 10−2μM, 10−1μM, 1 μM, or 10 μM of SB203580 (Sigma Aldrich), brefeldin A (BioLegend, CA, USA), PD153035 (Selleck, TX, USA), colchicine (WAKO), vincristine (Cayman, Michigan, USA), thapsigargin (WAKO, Osaka, Japan), and ML-240 (Sigma Aldrich, MO, USA) were added. After 24 h, the medium was discarded, and detection mix (PBS 12.5 μL, lytic buffer (Promega) 12.5 μL, substrate (Promega) 0.25 μL, and LgBiT (Promega) 0.125 μL) was added to each well.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!